TherML™ Platform
End-to-end, modality-agnostic system for designing small molecules, antibodies, oligonucleotides, and biologics.
Executive Summary
The TherML™ Platform by Insitro is an advanced, end-to-end, and modality-agnostic system engineered for the design of a wide range of therapeutics, including small molecules, antibodies, oligonucleotides, and other complex biologics. It leverages cutting-edge machine learning and statistical approaches to accelerate drug discovery and development. The platform is designed to analyze large-scale human cohorts, integrating multi-modal phenotypic and genetic data. This includes diverse data types such as dual-energy X-ray absorptiometry, H&E images, and comprehensive diagnostic information. By applying machine learning, TherML™ can predict critical biomarkers, such as liver fat content or molecular biomarkers from histological images, providing deep insights into various chronic disorders of aging, including neurodegenerative, ophthalmic, and metabolic diseases.
Use Cases
- Accelerating the design and discovery of novel small molecule therapeutics.
- Developing advanced antibodies and complex biologics for various diseases.
- Predicting molecular and digital biomarkers from multi-modal patient data.
- Analyzing large-scale human genetic and phenotypic cohorts for disease insights.
- Advancing research in neurodegenerative, ophthalmic, and metabolic disorders.
Features
Intelligence
- Multi-Modal Data Integration: Integrates and analyzes diverse data types including genetic, phenotypic, imaging, and diagnostic data from large cohorts.
- Biomarker Prediction: Predicts molecular and digital biomarkers (e.g., liver fat, H&E image biomarkers) using advanced machine learning.
- Therapeutic Design Guidance: Provides AI-driven insights and recommendations for the design of small molecules, antibodies, and biologics.
- Disease Mechanism Elucidation: Uncovers insights into chronic disorders of aging, such as neurodegenerative, ophthalmic, and metabolic diseases.
Technical Specifications
- Architecture
- Cloud-based platform leveraging machine learning and statistical models for multi-modal data analysis and therapeutic design.
- Deployment
- SaaS
AI/ML Stack
- Machine Learning
- Statistical Genetics
Pricing
- Target Customer
- Enterprise
About Insitro
Insitro is a machine learning-enabled drug discovery and development company that integrates multimodal data from human cohorts and cellular models with the power of AI and machine learning. The company aims to uncover genetic targets and new therapeutic hypotheses to accelerate the discovery and development of novel medicines.